RecruitingEarly Phase 1NCT05704283
3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer
3D Ultrasound Imaging of the Axillary Lymph Nodes
Sponsor
Mayo Clinic
Enrollment
55 participants
Start Date
Feb 14, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
This early phase I studies how well a new 3D ultrasound (3D-US) imaging technology works in evaluating lymph nodes in patients with breast cancer. Ultrasound uses high-frequency sound waves to generate images of the body.
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria2
- Patients with lymph node biopsy or lymph node clip placement as per routine clinical care.
- Age of 18 or older.
Exclusion Criteria1
- Vulnerable subjects such as prisoners and adults lacking capacity to consent.
Interventions
DEVICEUltrasound Imaging
Undergo 3D-US
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05704283
Related Trials
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
NCT06418204467 locations
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
NCT059415204 locations
The Vanguard Study: Testing a New Way to Screen for Cancer
NCT0699589836 locations
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
NCT0618475011 locations
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
NCT061953063 locations